Ablation Technology Market worth $27.56 billion by 2031
The report "Ablation Technology Market by Technology (Radiofrequency, Ultrasound, Microwave, Laser, Cryoablation, Pulse-field), Product (Systems, Consumables), Application (Cardiovascular, Cancer, Urological), End User (Hospitals, ASC) - Global Forecasts to 2031",is projected to grow from USD 16.18 billion in 2026 and to reach USD 27.56 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 11.2% during the forecast period.
Browse 300 market data Tables and 50 Figures spread through 350 Pages and in-depth TOC on "Ablation Technology Market by Technology (Radiofrequency, Ultrasound, Microwave, Laser, Cryoablation, Pulse-field), Product (Systems, Consumables), Application (Cardiovascular, Cancer, Urological), End User (Hospitals, ASC) - Global Forecasts to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html
The market is experiencing phenomenal growth because of increased occurrences of chronic disorders such as cardiovascular diseases, cancer, chronic pain disorders, and gynecological disorders, which will drive the demand for minimally invasive procedures. The rising preference for minimally invasive surgery over conventional surgery is one of the key reasons behind the rising demand for ablation therapies. The benefits associated with ablation include shorter hospital stays, quick recovery, low pain, reduced complications, and minimal scars. Additionally, the growing number of geriatrics around the world will fuel the growth of the market.
“By technology, radio frequency ablation segment to market during forecast period”
The technology segment of the ablation technologies market has been dominated by radiofrequency ablation due to its clinical use, effectiveness, and versatility. The technique makes use of the high-frequency electrical current, which generates heat to kill off the diseased tissues. The technique can be applied in the management of arrhythmias, cancers, chronic pains, and varicose veins. The increasing demand for radiofrequency ablation has been influenced by the minimally invasive nature of the technique, fast recovery period, reduced time spent in the hospital, and clinical success rates and safety. Radiofrequency ablation is considered the gold standard in the treatment of atrial fibrillation and other forms of heart rhythm disorders in cardiology. It has played a significant role in ensuring the dominance of the radiofrequency ablation in the market. Moreover, advancements in technology, including the development of RF ablation catheters, imaging and navigation systems, physician adoption, and favorable reimbursement policies, have solidified the position of radiofrequency ablation at the forefront of the ablation technologies market.
“By application, cardiovascular disease treatment segment to account for largest market share during forecast period”
By application, the cardiovascular disease treatment segment is estimated to lead the ablation technology market because of the increasing incidence of heart diseases, such as atrial fibrillation, atrial flutter, and other cardiac arrhythmias. High uptake of ablation technologies like radiofrequency ablation and pulsed field ablation (PFA) is observed in the field of cardiology. Some of the important factors responsible for the growth of the market are the rising number of elderly patients, prevalence of lifestyle diseases, and increased awareness regarding early detection and treatment. In addition, developments in mapping systems, catheters, and imaging technologies have made a significant contribution toward improving the efficiency of ablation therapy. Clinical benefits of ablation therapy, increased popularity of minimally invasive procedures, and reimbursement policies in many countries are some of the major factors supporting the growth of the segment.
“By region, North America accounted for largest market share in 2025”
The ablation technology market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The market is led by North America, largely driven by the high prevalence of chronic illnesses, including heart disease, cancer, and chronic pain. Additionally, the widespread adoption of advanced minimally invasive treatment techniques in the region contributes significantly to its dominant market share. The established health care system, high expenditure on healthcare, and favorable reimbursement policies have played a vital role in the extensive use of ablation technologies among hospitals and specialized clinics. The presence of key players in the medical devices industry within the region is also significantly contributing to the market's growth. These companies are actively engaged in R&D to create advanced ablation systems, including radiofrequency ablation, cryoablation, and pulsed field ablation (PFA).
Key Market Players :
The key players in the ablation technology market include Johnson & Johnson (US), Medtronic (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), ArtiCure, Inc. (US), AngioDynamics (US), CONMED Corporation (US), Olympus Corporation (Japan), and Varian Medical Systems, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Ablation Technology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
